Nuo Therapeutics, Inc. (AURX)
OTCMKTS
· Delayed Price · Currency is USD
1.010
0.00 (0.00%)
Jun 26, 2026, 4:00 PM EST
Nuo Therapeutics Employees
Nuo Therapeutics had 10 employees as of December 31, 2025. The number of employees increased by 1 or 11.11% compared to the previous year.
Employees
10
Change (1Y)
1
Growth (1Y)
11.11%
Revenue / Employee
$413,124
Profits / Employee
-$238,455
Market Cap
48.89M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Vicapsys Life Sciences | 2 |
| Cell Source | 1 |
| Provectus Biopharmaceuticals | 6 |
| Oncotelic Therapeutics | 43 |
| ZIVO Bioscience | 7 |
Nuo Therapeutics News
- 6 weeks ago - Nuo Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 6 months ago - Nuo Therapeutics initiated with a Buy at Roth Capital - TheFly
- 7 months ago - Nuo Therapeutics management to meet virtually with Roth Capital - TheFly
- 1 year ago - Nuo Therapeutics files $14M common stock offering - TheFly
- 1 year ago - Nuo Therapeutics enters Centrio distribution pact with Smith & Nephew - TheFly
- 1 year ago - Nuo Therapeutics Announces Exclusive Private Label Distribution Agreement with Smith+Nephew - GlobeNewsWire
- 1 year ago - Nuo Therapeutics, PAM Health partner to advance access to wound healing therapy - TheFly
- 1 year ago - Nuo Therapeutics and PAM Health Partner to Advance Access to Regenerative Wound Healing Therapies - GlobeNewsWire